<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>47(3)</volume><submitter>Saint-Maurice PF</submitter><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pubmed_abstract>&lt;h4>Study objectives&lt;/h4>To examine the associations between sleep duration, continuity, timing, and mortality using actigraphy among adults.&lt;h4>Methods&lt;/h4>Data were from a cohort of 88 282 adults (40-69 years) in UK Biobank that wore a wrist-worn triaxial accelerometer for 7 days. Actigraphy data were processed to generate estimates of sleep duration and other sleep characteristics including wake after sleep onset (WASO), number of 5-minute awakenings, and midpoint for sleep onset/wake-up and the least active 5 hours (L5). Data were linked to mortality outcomes with follow-up to October 31, 2021. We implemented Cox models (hazard ratio, confidence intervals [HR, 95% CI]) to quantify sleep associations with mortality. Models were adjusted for demographics, lifestyle factors, and medical conditions.&lt;h4>Results&lt;/h4>Over an average of 6.8 years 2973 deaths occurred (1700 cancer, 586 CVD deaths). Overall sleep duration was significantly associated with risk for all-cause (p &lt; 0.01), cancer (p &lt; 0.01), and CVD (p = 0.03) mortality. For example, when compared to sleep durations of 7.0 hrs/d, durations of 5 hrs/d were associated with a 29% higher risk for all-cause mortality (HR: 1.29 [1.09, 1.52]). WASO and number of awakenings were not associated with mortality. Individuals with L5 early or late midpoints (&lt;2:30 or ≥ 3:30) had a ~20% higher risk for all-cause mortality, compared to those with intermediate L5 midpoints (3:00-3:29; p ≤ 0.01; e.g. HR ≥ 3:30: 1.19 [1.07, 1.32]).&lt;h4>Conclusions&lt;/h4>Shorter sleep duration and both early and late sleep timing were associated with a higher mortality risk. These findings reinforce the importance of public health efforts to promote healthy sleep patterns in adults.</pubmed_abstract><journal>Sleep</journal><pagination>zsad312</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10925955</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Associations between actigraphy-measured sleep duration, continuity, and timing with mortality in the UK Biobank.</pubmed_title><pmcid>PMC10925955</pmcid><pubmed_authors>Saint-Maurice PF</pubmed_authors><pubmed_authors>Almeida JS</pubmed_authors><pubmed_authors>Watts EL</pubmed_authors><pubmed_authors>Russ D</pubmed_authors><pubmed_authors>Shams-White MM</pubmed_authors><pubmed_authors>Patel S</pubmed_authors><pubmed_authors>Hong HG</pubmed_authors><pubmed_authors>Wolff-Hughes DL</pubmed_authors><pubmed_authors>Loftfield E</pubmed_authors><pubmed_authors>Moore SC</pubmed_authors><pubmed_authors>Freeman JR</pubmed_authors><pubmed_authors>Matthews CE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Associations between actigraphy-measured sleep duration, continuity, and timing with mortality in the UK Biobank.</name><description>&lt;h4>Study objectives&lt;/h4>To examine the associations between sleep duration, continuity, timing, and mortality using actigraphy among adults.&lt;h4>Methods&lt;/h4>Data were from a cohort of 88 282 adults (40-69 years) in UK Biobank that wore a wrist-worn triaxial accelerometer for 7 days. Actigraphy data were processed to generate estimates of sleep duration and other sleep characteristics including wake after sleep onset (WASO), number of 5-minute awakenings, and midpoint for sleep onset/wake-up and the least active 5 hours (L5). Data were linked to mortality outcomes with follow-up to October 31, 2021. We implemented Cox models (hazard ratio, confidence intervals [HR, 95% CI]) to quantify sleep associations with mortality. Models were adjusted for demographics, lifestyle factors, and medical conditions.&lt;h4>Results&lt;/h4>Over an average of 6.8 years 2973 deaths occurred (1700 cancer, 586 CVD deaths). Overall sleep duration was significantly associated with risk for all-cause (p &lt; 0.01), cancer (p &lt; 0.01), and CVD (p = 0.03) mortality. For example, when compared to sleep durations of 7.0 hrs/d, durations of 5 hrs/d were associated with a 29% higher risk for all-cause mortality (HR: 1.29 [1.09, 1.52]). WASO and number of awakenings were not associated with mortality. Individuals with L5 early or late midpoints (&lt;2:30 or ≥ 3:30) had a ~20% higher risk for all-cause mortality, compared to those with intermediate L5 midpoints (3:00-3:29; p ≤ 0.01; e.g. HR ≥ 3:30: 1.19 [1.07, 1.32]).&lt;h4>Conclusions&lt;/h4>Shorter sleep duration and both early and late sleep timing were associated with a higher mortality risk. These findings reinforce the importance of public health efforts to promote healthy sleep patterns in adults.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-03T23:52:46.047Z</modification><creation>2025-04-03T23:52:46.047Z</creation></dates><accession>S-EPMC10925955</accession><cross_references><pubmed>38066693</pubmed><doi>10.1093/sleep/zsad312</doi></cross_references></HashMap>